Results 1 to 10 of about 291,982 (298)

Accumulation of Tau Protein, Metabolism and Perfusion—Application and Efficacy of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Imaging in the Examination of Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS)

Frontiers in Neurology, 2019
Neuroimaging in the context of examining atypical parkinsonian tauopathies is an evolving matter. Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) bring tools, which may be reasonable in supplementary examination,
Piotr Alster, Natalia Katarzyna Madetko, Dariusz Mariusz Koziorowski, Leszek Królicki, Sławomir Budrewicz, Andrzej Friedman   +5 more
doaj   +3 more sources

PET/CT Radiomic Features: A Potential Biomarker for EGFR Mutation Status and Survival Outcome Prediction in NSCLC Patients Treated With TKIs

Frontiers in Oncology, 2022
BackgroundsEpidermal growth factor receptor (EGFR) mutation profiles play a vital role in treatment strategy decisions for non–small cell lung cancer (NSCLC).
Liping Yang, Panpan Xu, Mengyue Li, Menglu Wang, Mengye Peng, Ying Zhang, Tingting Wu, Wenjie Chu, Kezheng Wang, Hongxue Meng, Lingbo Zhang   +10 more
doaj   +1 more source

Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma

Frontiers in Oncology, 2021
PurposeTo develop and validate the radiomics nomogram that combines clinical factors and radiomics features to estimate overall survival (OS) in patients with clear cell renal cell carcinoma (ccRCC), and assess the incremental value of radiomics for OS ...
Lei Yan, Guangjie Yang, Jingjing Cui, Wenjie Miao, Yangyang Wang, Yujun Zhao, Ning Wang, Aidi Gong, Na Guo, Pei Nie, Zhenguang Wang   +10 more
doaj   +1 more source

Predictive value of baseline metabolic tumor burden on 18F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer

Frontiers in Oncology, 2022
ObjectivesBrain metastases (BMs) are a major cause leading to the failure of treatment management for non-small-cell lung cancer (NSCLC) patients. The purpose of this study was to evaluate the predictive value of baseline metabolic tumor burden on 18F ...
Jingjie Shang, Huimin You, Chenchen Dong, Yingxin Li, Yong Cheng, Yongjin Tang, Bin Guo, Jian Gong, Xueying Ling, Hao Xu   +9 more
doaj   +1 more source

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer

Frontiers in Oncology, 2022
BackgroundThe aim of this study was to evaluate the clinical usefulness of radiomics signature-derived 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) for the early prediction of neoadjuvant chemotherapy (NAC ...
Liping Yang, Jianfei Chang, Xitao He, Mengye Peng, Ying Zhang, Tingting Wu, Panpan Xu, Wenjie Chu, Chao Gao, Shaodong Cao, Shi Kang   +10 more
doaj   +1 more source

Habitat Imaging-Based 18F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases

Frontiers in Oncology, 2021
PurposeTo propose and evaluate habitat imaging-based 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) radiomics for preoperatively discriminating non-small cell lung cancer (NSCLC) and benign inflammatory ...
Ling Chen, Kanfeng Liu, Xin Zhao, Hui Shen, Kui Zhao, Wentao Zhu   +5 more
doaj   +1 more source

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

Frontiers in Oncology, 2023
ObjectivesLung cancer has been widely characterized through radiomics and artificial intelligence (AI). This review aims to summarize the published studies of AI based on positron emission tomography/computed tomography (PET/CT) radiomics in non-small ...
Qiuyuan Hu, Ke Li, Conghui Yang, Yue Wang, Rong Huang, Mingqiu Gu, Yuqiang Xiao, Yunchao Huang, Long Chen   +8 more
doaj   +1 more source

Positron Emission Tomography (PET) in Oncology [PDF]

Cancers, 2014
Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment during or after treatment end and radiotherapy planning ...
Gallamini, Andrea, Zwarthoed, Colette, Borra, Anna   +2 more
openaire   +2 more sources

PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging

Frontiers in Neuroscience, 2022
The development of novel PET imaging agents for synaptic vesicle glycoprotein 2A (SV2A) allowed for the in vivo detection of synaptic density changes, which are correlated with the progression and severity of a variety of neuropsychiatric diseases. While
Takuya Toyonaga, Arman Fesharaki-Zadeh, Arman Fesharaki-Zadeh, Stephen M. Strittmatter, Stephen M. Strittmatter, Richard E. Carson, Zhengxin Cai   +6 more
doaj   +1 more source

Positron emission tomography (PET) for cholangiocarcinoma [PDF]

HPB, 2008
The combination of positron emission tomography (PET) with computed tomography (PET-CT) provides simultaneous metabolic and anatomic information on tumors in the same imaging session. Sensitivity of PET/PET-CT is higher for intrahepatic (>90%) than for extrahepatic cholangiocarcinoma (CCA) (about 60%). The detection rate of distant metastasis is 100%
Breitenstein, S, Apestegui, C, Clavien, P A   +2 more
openaire   +3 more sources